相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。How we manage Philadelphia-negative myeloproliferative neoplasms in pregnancy
Susan E. Robinson et al.
BRITISH JOURNAL OF HAEMATOLOGY (2020)
Use of Interferon Alfa in the Treatment of Myeloproliferative Neoplasms: Perspectives and Review of the Literature
Joan How et al.
CANCERS (2020)
Association of Treatments for Myeloproliferative Neoplasms During Pregnancy With Birth Rates and Maternal Outcomes A Systematic Review and Meta-analysis
Dawn Maze et al.
JAMA NETWORK OPEN (2019)
Philadelphia chromosome-negative classical myeloproliferative neoplasms: revised management recommendations from European LeukemiaNet
Tiziano Barbuil et al.
LEUKEMIA (2018)
Contemporary management of patients with BCR-ABL1-negative myeloproliferative neoplasms during pregnancy
Martin Griesshammer et al.
EXPERT REVIEW OF HEMATOLOGY (2018)
Risk of venous thromboembolism in pregnant women with essential thrombocythemia: a systematic review and meta-analysis
Leslie Skeith et al.
BLOOD (2017)
Pegylated interferon alpha-2a for essential thrombocythemia during pregnancy: outcome and safety. A case series
Yan Beauverd et al.
HAEMATOLOGICA (2016)
Pegylated interferon alpha-2a for essential thrombocythemia during pregnancy: outcome and safety. A case series
Yan Beauverd et al.
HAEMATOLOGICA (2016)
Impact of mutational status on pregnancy outcome in patients with essential thrombocytemia
Elisa Rumi et al.
HAEMATOLOGICA (2015)
Impact of mutational status on pregnancy outcome in patients with essential thrombocytemia
Elisa Rumi et al.
HAEMATOLOGICA (2015)
Pregnancy complications predict thrombotic events in young women with essential thrombocythemia
Maria Luigia Randi et al.
AMERICAN JOURNAL OF HEMATOLOGY (2014)
Long-term survival and blast transformation in molecularly annotated essential thrombocythemia, polycythemia vera, and myelofibrosis
Ayalew Tefferi et al.
BLOOD (2014)
Development and validation of an International Prognostic Score of thrombosis in World Health Organization-essential thrombocythemia (IPSET-thrombosis)
Tiziano Barbui et al.
BLOOD (2012)
Risk of first venous thromboembolism in and around pregnancy: a population-based cohort study
Alyshah Abdul Sultan et al.
BRITISH JOURNAL OF HAEMATOLOGY (2012)
Philadelphia-Negative Classical Myeloproliferative Neoplasms: Critical Concepts and Management Recommendations From European LeukemiaNet
Tiziano Barbui et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Definition of major bleeding in clinical investigations of antihemostatic medicinal products in surgical patients
S. Schulman et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2010)
Outcome of 122 pregnancies in essential thrombocythemia patients: A report from the Italian registry
Lorella Melillo et al.
AMERICAN JOURNAL OF HEMATOLOGY (2009)
The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes
James W. Vardiman et al.
BLOOD (2009)
Predictors of pregnancy outcome in essential thrombocythemia: a single institution study of 63 pregnancies
Naseema Gangat et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2009)
Management of Philadelphia negative chronic myeloproliferative disorders in pregnancy
Martin Griesshammer et al.
BLOOD REVIEWS (2008)
Side effects of interferon-α therapy
S Sleijfer et al.
PHARMACY WORLD & SCIENCE (2005)
Pregnancy and its management in the Philadelphia negative myeloproliferative diseases
C Harrison
BRITISH JOURNAL OF HAEMATOLOGY (2005)
Pregnancy in essential thrombocythaemia: experience with 40 pregnancies
R Niittyvuopio et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2004)
Interferon alfa treatment for pregnant women affected by essential thrombocythemia: Case reports and a review
P Martinelli et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2004)
Maternal age and fetal loss: population based register Linkage study
AMN Andersen et al.
BRITISH MEDICAL JOURNAL (2000)
Management of essential thrombocythaemia during pregnancy
R Cincotta et al.
AUSTRALIAN & NEW ZEALAND JOURNAL OF OBSTETRICS & GYNAECOLOGY (2000)